Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Antiobesity Market Report 2024

Antiobesity Global Market Report 2024 – By Drug Class (Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs), By Type (Prescription Drugs (Rx), OTC Drugs), By Medication (Monotherapies, Polytherapies) – Market Size, Trends, And Global Forecast 2024-2033

Antiobesity Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Antiobesity Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Antiobesity Market Definition

The anti-obesity drugs refer to the medications that are used to lower or regulate weight of a patient. These drugs interfere with one of the body's basic functions, controlling weight, by affecting either appetite or calorie absorption. Dieting (a healthy diet and caloric restriction) and exercise continue to be the main therapeutic approaches for overweight and obese people.

The main classes of drugs in anti-obesity are peripherally acting anti-obesity drugs and centrally acting anti-obesity drugs. Antiobesity medications with a peripheral effect help people lose weight without influencing the brain or decreasing their appetite. It blocks pancreatic lipase and hinders fat breakdown in the gastrointestinal tract, lowering fat absorption through the intestine. The different types of drugs include prescription drugs (Rx), and OTC drugs and involve various medications such as monotherapies and polytherapy.

Antiobesity Market Segmentation

The antiobesity market covered in this report is segmented –

1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs

2) By Type: Prescription Drugs (Rx), OTC Drugs

3) By Medication: Monotherapies, Polytherapies

Global Antiobesity Market Size 2023 to 2028: Graph

Antiobesity Market Size 2024 And Growth Rate

The antiobesity market size has grown rapidly in recent years. It will grow from $3.38 billion in 2023 to $3.76 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing obesity prevalence, awareness and education, lifestyle changes, government initiatives.

Antiobesity Market Growth Forecast

The antiobesity market size is expected to see rapid growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to market expansion, globalization. Major trends in the forecast period include research and development, patient-centric approaches, insurance coverage, technological advancements, digital health and telemedicine, novel drug therapies, bariatric surgery advancements, otc (over-the-counter) solutions, behavioral interventions, nutritional and weight management apps.

Book your 30 minutes free consultation with our research experts

Contact Us

Antiobesity Market Driver: Rising Prevalence Rate Of Obesity In The Anti-Obesity Drugs Market

Obesity is a major public health concern globally. Globally, the prevalence rate of obesity is increasing every year. For instance, in May 2022, according to the World Obesity Atlas, a UK-based obesity organization, globally, it is estimated that more than 1 billion people will be suffering from obesity by 2030. This can be attributed to increased consumption of processed and unhealthy food, lack of physical activity, and lack of awareness of the risks of obesity. As a result, the demand for anti-obesity drugs is bound to increase in the future thus, driving the market growth.

Antiobesity Market Driver: Rising Geriatric Population

The rising geriatric population is expected to propel the growth of the anti obesity drugs market going forward. The geriatric population refers to the segment of the elderly or older, typically aged 65 and older. Anti-obesity drugs are a common and significant concern within the senior population. Elderly individuals with diabetes are particularly susceptible to obesity due to less body movement, reduced proper circulation of blood throughout the body. For instance, in October 2022, according to reports shared by the World Health Organization, a US-based specialized health agency, globally, 1 in 6 individuals will be 60 or older by 2030, and by 2050, there will be a double number of individuals in this age group (2.1 billion). Therefore, the rising geriatric population is driving the growth of the anti-obesity drugs market.

Global Antiobesity Market Major Players

Major companies operating in the antiobesity market include F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Novartis International AG, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Allergan Aesthetics, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Intas Pharmaceuticals Ltd., Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd.

Global Antiobesity Market Restraint: Challenges And Concerns In The Anti-Obesity Drug Market

Obesity is a major health problem worldwide which is caused by leading a sedentary lifestyle and consumption of unhealthy food. Though various anti-obesity drugs have been approved and are available in the USA, European Union, Australia, and Japan to treat obesity and overweight. It has been observed that these drugs have various adverse effects on patients undergoing obesity treatment. Adverse effects include low blood pressure and blood glucose, incontinence, insomnia, nausea, diarrhea, and others. For instance, Sibutramine and its combination drugs sold under various brands were recalled in various countries due to various side effects including a heart attack in consumers. These factors restrain the growth of the anti-obesity drug market.

Global Antiobesity Market Trend: Product Innovations In The Anti-Obesity Drug Market

Major companies operating in the anti-obesity drugs market are focusing on innovating new products, such as Mounjaro (tirzepatide), to provide reliable services to customers. Mounjaro (tirzepatide) is used as an anti-obesity drug for the treatment of adults with obesity or overweight with weight-related comorbidities. For instance, in October 2022, Eli Lilly and Company,a US-based pharmaceutical company, launched Mounjaro (tirzepatide), approved by the Food and Drug Administration (FDA), a US-based federal agency, as a fast track designation treatment. Mounjaro (tirzepatide) is an injectable form of anti-obesity drug used to help individuals struggling with obesity achieve their weight loss goals. This is used for adults with type 2 diabetes, along with diet and exercise, to improve blood sugar (glucose).

Global Antiobesity Market Trend: Strategic Collaborations In The Anti-Obesity Drug Market

The pharmaceutical industry is witnessing an increase in the number of mergers and acquisitions among companies developing drugs for metabolic disorders such as obesity, diabetes, and others. This is a strategy of pharmaceutical companies to strengthen their drug portfolio in metabolic diseases and launch safe and effective drugs in the market. For instance, Evotec AG and Novo Nordisk entered into a strategic alliance to able to discover and develop drug molecules to treat metabolic disorders including obesity, diabetes, and other associated disorders.

Regional Analysis For The Global Antiobesity Market

North America was the largest region in the anti-obesity market in 2023. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the antiobesity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The anti-obesity market consists of sales of liraglutide, semaglutide, naltrexone-bupropion, and orlistat. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The anti-obesity market research report is one of a series of new reports from The Business Research Company that provides anti-obesity market statistics, including anti-obesity industry global market size, regional shares, competitors with an anti-obesity market share, detailed anti-obesity market segments, market trends and opportunities, and any further data you may need to thrive in the anti-obesity industry. This anti-obesity market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Antiobesity Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $3.76 billion
Revenue Forecast In 2033 $5.64 billion
Growth Rate CAGR of 10.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs
2) By Type: Prescription Drugs (Rx), OTC Drugs
3) By Medication: Monotherapies, Polytherapies
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG; GlaxoSmithKline plc; Boehringer Ingelheim GmbH; Pfizer Inc.; Merck & Co. Inc.; Takeda Pharmaceutical Company Limited; Eisai Co. Ltd.; Novo Nordisk A/S; Zafgen Inc.; Rhythm Pharmaceuticals Inc.; Zydus Cadila; Norgine B.V.; Vivus Inc.; Arena Pharmaceuticals Inc.; Orexigen Therapeutics Inc.; Eli Lilly and Company; Amgen Inc.; AstraZeneca PLC; Novartis International AG; Viking Therapeutics Inc.; Structure Therapeutics Inc.; Gelesis Inc.; Sanofi S.A.; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Teva Pharmaceutical Industries Limited; Allergan Aesthetics; Sun Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Cipla Ltd.; Lupin Ltd.; Torrent Pharmaceuticals Ltd.; Cadila Healthcare Ltd.; Intas Pharmaceuticals Ltd.; Wockhardt Ltd.; Glenmark Pharmaceuticals Ltd.; Alkem Laboratories Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Antiobesity Market Characteristics

    3. Antiobesity Market Trends And Strategies

    4. Antiobesity Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Antiobesity Market Size and Growth

    5.1. Global Antiobesity Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Antiobesity Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Antiobesity Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Antiobesity Market Segmentation

    6.1. Global Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Prescription Drugs (Rx)

    OTC (over the counter) Drugs

    6.2. Global Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Peripherally Acting Anti Obesity Drugs

    Centrally Acting Anti Obesity Drugs

    6.3. Global Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Monotherapies

    Polytherapies

    7. Antiobesity Market Regional And Country Analysis

    7.1. Global Antiobesity Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Antiobesity Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Antiobesity Market

    8.1. Asia-Pacific Antiobesity Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Antiobesity Market

    9.1. China Antiobesity Market Overview

    9.2. China Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Antiobesity Market

    10.1. India Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Antiobesity Market

    11.1. Japan Antiobesity Market Overview

    11.2. Japan Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Antiobesity Market

    12.1. Australia Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Antiobesity Market

    13.1. Indonesia Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Antiobesity Market

    14.1. South Korea Antiobesity Market Overview

    14.2. South Korea Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Antiobesity Market

    15.1. Western Europe Antiobesity Market Overview

    15.2. Western Europe Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Antiobesity Market

    16.1. UK Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Antiobesity Market

    17.1. Germany Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Antiobesity Market

    18.5. France Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Antiobesity Market

    19.9. Italy Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Antiobesity Market

    20.13. Spain Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Antiobesity Market

    21.1. Eastern Europe Antiobesity Market Overview

    21.2. Eastern Europe Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Antiobesity Market

    22.1. Russia Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Antiobesity Market

    23.1. North America Antiobesity Market Overview

    23.2. North America Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Antiobesity Market

    24.1. USA Antiobesity Market Overview

    24.2. USA Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Antiobesity Market

    25.1. Canada Antiobesity Market Overview

    25.2. Canada Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Antiobesity Market

    26.1. South America Antiobesity Market Overview

    26.2. South America Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Antiobesity Market

    27.1. Brazil Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Antiobesity Market

    28.1. Middle East Antiobesity Market Overview

    28.2. Middle East Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Antiobesity Market

    29.1. Africa Antiobesity Market Overview

    29.2. Africa Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Antiobesity Market Competitive Landscape And Company Profiles

    30.1. Antiobesity Market Competitive Landscape

    30.2. Antiobesity Market Company Profiles

    30.2.1. F. Hoffmann-La Roche AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. GlaxoSmithKline plc

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Boehringer Ingelheim GmbH

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Pfizer Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Merck & Co. Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Antiobesity Market Competitive Benchmarking

    32. Global Antiobesity Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Antiobesity Market

    34. Antiobesity Market Future Outlook and Potential Analysis

    34.1 Antiobesity Market In 2028 - Countries Offering Most New Opportunities

    34.2 Antiobesity Market In 2028 - Segments Offering Most New Opportunities

    34.3 Antiobesity Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Antiobesity Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Antiobesity Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: F. Hoffmann-La Roche AG Financial Performance
  • Table 75: GlaxoSmithKline plc Financial Performance
  • Table 76: Boehringer Ingelheim GmbH Financial Performance
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: Merck & Co. Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Antiobesity Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Antiobesity Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Antiobesity Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Antiobesity Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Antiobesity Market, Segmentation By Medication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: F. Hoffmann-La Roche AG Financial Performance
  • Figure 75: GlaxoSmithKline plc Financial Performance
  • Figure 76: Boehringer Ingelheim GmbH Financial Performance
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: Merck & Co. Inc. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

Read More

Organ-On-Chip (OOC) Market 2021 - By Organ Type (Lung-On-Chip, Heart-On-Chip, Liver-On-Chip, Intestine-On-Chip, Kidney-On-Chip, Skin-On-Chip, Blood-Brain-Barrier-On-Chip), By Application (Toxicology Research, Drug Discovery, Molecular Biology, Disease Modelling, Food Safety), By End-User (Biopharmaceutical companies, Academics, Food & Beverages), By Products and Services (Devices, Testing Services), By Type Of Material (Polymer, PDMS, Glass, Silicon), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Smart Pills Global Market Report 2024 – By Target Area (Esophagus, Stomach, Small Intestine, Large Intestine), By Disease Indication (Esophageal Diseases, Colon Diseases, Small bowel Diseases, and Other Disease Indications), By Application (Capsule Endoscopy, Patient Monitoring, Drug Delivery), By End User (Hospital, Diagnostic Center, Research Institute) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Oral Contraceptive Pills Global Market Report 2024 – By Type (Combination, Progestin Only, Other Types), By Category (Generic, Branded), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Total Station Global Market Report 2024 – By Type (Robotic, Manual), By Component (Software, Hardware), By Application (Oil & Gas, Mining, Agriculture, Construction, Transportation, Utilities, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Nickel Global Market Report 2024 – By Type (Pentlandite (Sulfide Ore), Laterite), By Mining Type (Underground Mining, Surface Mining) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Hormonal Contraceptives Global Market Report 2024 – By Product (Pills, Injectable Birth Control, Vaginal Rings, Others), By End User (Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers), By Hormones (Progestin-Only, Combined Hormones), By Distribution Channel (Drug Stores, Gynecology/ Fertility Clinics, E-Commerce, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cough And Cold Preparations Global Market Report 2024 – By Drug Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Other Drug Types), By Dosage Type (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Other Dosage Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the antiobesity market?

The anti-obesity drugs refer to the medications that are used to lower or regulate weight of a patient. These drugs interfere with one of the body's basic functions, controlling weight, by affecting either appetite or calorie absorption. Dieting (a healthy diet and caloric restriction) and exercise continue to be the main therapeutic approaches for overweight and obese people. For further insights on the antiobesity market, request a sample here

How will the antiobesity market drivers and restraints affect the antiobesity market dynamics? What forces will shape the antiobesity industry going forward?

The antiobesity market major growth driver - rising prevalence rate of obesity in the anti-obesity drugs market. For further insights on the antiobesity market, request a sample here

What is the forecast market size or the forecast market value of the antiobesity market ?

The antiobesity market size has grown rapidly in recent years. It will grow from $3.38 billion in 2023 to $3.76 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing obesity prevalence, awareness and education, lifestyle changes, government initiatives. The antiobesity market size is expected to see rapid growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to market expansion, globalization. Major trends in the forecast period include research and development, patient-centric approaches, insurance coverage, technological advancements, digital health and telemedicine, novel drug therapies, bariatric surgery advancements, otc (over-the-counter) solutions, behavioral interventions, nutritional and weight management apps. For further insights on the antiobesity market, request a sample here

How is the antiobesity market segmented?

The antiobesity market is segmented
1) By Drug Class: Peripherally acting anti obesity drugs; Centrally acting anti obesity drugs
2) By Type: Prescription Drugs (Rx); OTC Drugs
3) By Medication: Monotherapies; Polytherapies For further insights on the antiobesity market, request a sample here

Which region has the largest share of the antiobesity market? What are the other regions covered in the report?

North America was the largest region in the anti-obesity market in 2023. Middle East is expected to be the fastest-growing region in the antiobesity market. The regions covered in the antiobesity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the antiobesity market, request a sample here.

Who are the major players in the antiobesity market?

Major companies operating in the antiobesity market include F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen Inc., Rhythm Pharmaceuticals Inc., Zydus Cadila, Norgine B.V., Vivus Inc., Arena Pharmaceuticals Inc., Orexigen Therapeutics Inc., Eli Lilly and Company, Amgen Inc., AstraZeneca PLC, Novartis International AG, Viking Therapeutics Inc., Structure Therapeutics Inc., Gelesis Inc., Sanofi S.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Limited, Allergan Aesthetics, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Intas Pharmaceuticals Ltd., Wockhardt Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd. For further insights on the antiobesity market, request a sample here.

What are the key trends in the antiobesity market?

Major trend in the antiobesity market - product innovations in the anti-obesity drug market. For further insights on the antiobesity market, request a sample here.

What are the major opportunities in the antiobesity market? What are the strategies for the antiobesity market?

For detailed insights on the major opportunities and strategies in the antiobesity market, request a sample here.

How does the antiobesity market relate to the overall economy and other similar markets?

For detailed insights on antiobesity market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the antiobesity industry?

For detailed insights on the mergers and acquisitions in the antiobesity industry, request a sample here.

What are the key dynamics influencing the antiobesity market growth? SWOT analysis of the antiobesity market.

For detailed insights on the key dynamics influencing the antiobesity market growth and SWOT analysis of the antiobesity industry, request a sample here.